| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |